Becerra-Lemus JF, Rincón-Herrera DF, Restrepo-Vanegas LC, Vargas-Rodríguez LJ

Language: Spanish
References: 12
Page: 113-117
PDF size: 381.25 Kb.

ABSTRACT

Background: Melioidosis is a bacterial disease that affects humans and many species of animals, it is caused for gram-negative bacillus Burkholderia pseudomallei.
Clinical case: A female 57-year-old patient was admitted for a clinical picture of five days of febrile peaks of 39°C associated with chest pain, dyspnea and daily bowel movements. In the physical examination with decrease of vesicular volume in apex of right lung. The chest radiograph showed a radiopacity that was better compromised with the right lung; however, due to the results of the computed tomography a pulmonary abscess was considered and antibiotic treatment was changed and a pulmonary drainage was done. Finally, the cultures demonstrated the presence of B. pseudomallei, for which the antibiotic treatment was adjusted, obtaining an adequate clinical evolution of the patient.
Conclusion: Melioidosis has an incidence of 21 new cases per 100,000 people per year, affecting when there are risk factors such as diabetes, alcoholism, chronic lung disease, thalassemia, chronic kidney disease, cancer, use of radio or chemotherapy, and consumption of glucocorticoids, among others.

REFERENCES

1. The Center For Food Security and Public Health, Iowa State University, Melioidosis, Pseudoglanders, Whitmore Disease, January 2016, Available from: http://www.cfsph. iastate.edu/Factsheets/pdfs/melioidosis.pdf.

2. Wiersinga WJ, Currie BJ, Peacock SJ.. Melioidosis. N Engl J Med 2012;367:1035-1044. doi: 10.1056/NEJMra1204699.

3. Rolim DB, Ximenes R, Lima R. Melioidosis in South America. Trop Med Infect Dis 2018 June;60(3). doi:10.3390/ tropicalmed3020060.

4. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008;102(Suppl 1):S1-S4. doi: 10.1016/S0035-9203(08)70002-6.

5. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2015;18:383- 416. DOI: 10.1128/CMR.18.2.383-416.2005.

6. Wuthiekanun V, Chierakul W, Langa S, Chaowagul W, Panpitpat C, Saipan P, Thoujaikong T, Day NP, Peacock SJ. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis endemic northeast Thailand. Am J Trop Med Hyg 2006;74:1074-1075.

7. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop. 2000;74:121-127. DOI: 10.1016/ s0001-706x(99)00060-1.

8. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010;4:e900. doi: 10.1371/journal.pntd.0000900.

9. Kingsley PV, Arunkumar G, Tipre M, Leader M, Sathiakumar N. Pitfalls and optimal approaches to diagnose melioidosis. Asian Pac J Trop Med 2016;9(6):515-524. doi: 10.1016/j. apjtm.2016.04.003.

10. Peeters M, Chung P, Lin H, Mortelmans K, Phe C, San C, et al. Diagnostic accuracy of the InBiOS AMD rapid diagnostic test for the detection of Burkholderia pseudomallei antigen in grown blood culture broth. Eur J Clin Microbiol Infect Dis 2018;37:1169-1177. doi: 10.1007/ s10096-018-3237-3.

11. Limmathurotsakul D, Peacock SJ. Melioidosis: a clinical overview. Br Med Bull 2011;99:125-139. doi: 10.1093/ bmb/ldr007.

12. Zong Z, Wang X, Deng Y, Zhou T. Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system. J Med Microbiol 2012;61:1483-1484. doi: 10.1099/jmm.0.041525-0.